Net Cash Provided by (Used in) Operating Activities |
-21.6K |
USD |
-8.05% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
21.5K |
USD |
+7.07% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Shares, Issued |
14M |
shares |
0% |
Q4 2024 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
677 |
USD |
+31.7% |
Q4 2024 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
344 |
USD |
-1.71% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
165K |
USD |
+6.87% |
Q1 2023 |
Q3 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
189K |
USD |
+3.27% |
Q4 2024 |
Q2 2025 |
Property, Plant and Equipment, Gross |
700 |
USD |
0% |
Q4 2024 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Operating Loss Carryforwards |
179K |
USD |
+2.94% |
Q4 2024 |
Q2 2025 |
Current Income Tax Expense (Benefit) |
0 |
USD |
|
Q3 2024 |
Q1 2025 |
Additional Paid in Capital |
433K |
USD |
0% |
Q4 2024 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
Q2 2025 |
Interest Expense |
10.4K |
USD |
+0.34% |
Q4 2024 |
Q2 2025 |